Napier Park Global Capital (US)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Napier Park Global Capital (US)'s PFE Position: Q3 2019 in Review
Napier Park Global Capital (US) sold out of Pfizer (PFE) in Q3 2019, closing a stake of 29,512 shares — an estimated $1.21M sold.
Napier Park Global Capital (US) first reported a position in PFE in Q2 2019 and held it in 1 quarter. The position peaked at $1.21M in Q2 2019. 2,322 funds tracked by Wall St. Rank hold PFE as of Q3 2019.
- Napier Park Global Capital (US) reported no remaining Pfizer position as of Q3 2019 after selling out during the quarter.
- Napier Park Global Capital (US) sold 29,512 Pfizer shares in Q3 2019, an estimated $1.21M.
- Napier Park Global Capital (US) first reported a position in Pfizer in Q2 2019 and held it in 1 quarter.
- Napier Park Global Capital (US)'s Pfizer position peaked at $1.21M in Q2 2019.
- 2,322 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.
Based on Napier Park Global Capital (US)'s 13F filing for Q3 2019, filed 13 Nov 2019.